How pharma can overcome inflation (with abstract)
| How pharma can overcome inflation (with abstract) | |
|---|---|
| Published By | [[Pharma manufacturing]] |
| Publish Date | Sept. 14, 2022 |
| Authors | Cathy Tie |
| Topics | B2B eCommerce in Pharma |
| Statistics | |
| Article Size | words |
| Diagrams | No |
| Downloadable Version | No |
| Reviewers | |
| Page Owner | Nikolay Sidelnikov |
| Summary Author | Nikolay Sidelnikov |
Abstract
The article How pharma can overcome inflation was published by Pharma manufacturing in 2022. It describes the potential effect of D2C business model that according to the article may reel in excess costs and increase user adoption without sacrificing margins — while still passing on the savings to patients.
The author points that drug eCommerce channel is already tested by multiple niche players and assumes that large pharmaceutical brands can’t take advantage of this momentum by launching their own DTC e-commerce brand.
The following potential benefits of this approach are listed:
- Cutting out the middlemen would decrease the overall cost of drugs for consumers
- Build direct contact with consumers and increase patient adoption
- Increase profit without raising prices
- Increased brand recognition due to building direct contact with patient
Quote
New e-commerce solutions, digital marketing platforms and backend tools have made it easier for pharma companies to take ownership of the entire supply chain.
Full article: How pharma can overcome inflation